Breaking

Biotech investors have been showing a lot of interest in the field of autoimmune diseases this year. While the obesity market is also attracting attention, autoimmune conditions have been at the forefront of drug...

SalioGen Therapeutics, a biotech company that secured $135 million in funding to develop a cutting-edge gene-editing technology, is facing a challenging situation as it recently laid off a significant number of employees and adjusted...

As the week comes to a close, many of us are looking forward to the weekend. Whether it's spending time with family, enjoying the outdoors, or simply relaxing, we all have our own plans....

Imagine a world where your elderly mother could receive quality care at home without bankrupting your family. Now picture that same world, but with a twist: The caregiver isn’t a typical home care worker,...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.“To encourage robust, good-faith discussion about issues raised...

Vice President Kamala Harris has recently received a positive health report, indicating that she is in excellent health and possesses the physical and mental resilience needed to serve as president. The report was released...

Sanofi, a French drugmaker, is in talks to sell a 50% stake in its consumer health business, Opella, for $16 billion to a U.S. private equity firm. Camp4 Therapeutics raised $75 million in an...

The Food and Drug Administration, or FDA, announced on Friday that it would be revisiting its decision to remove Eli Lilly's tirzepatide, which is known as Mounjaro for diabetes and Zepbound for obesity, from...

Since the Nobel Prizes were established in 1901, only 24 women have been recognized in the field of science. This year, the trend continued as all seven laureates in physics, chemistry, and physiology or...

Pharmalot Columnist, Senior WriterHave you recently hired a new and exciting employee? Promoted a rising star within your company? Finally filled a challenging position? Don't keep it to yourself - share the news with...

The battle over blockbuster weight loss medications is intensifying, and patients are finding themselves caught in the middle. The Food and Drug Administration recently announced the end of the shortage of Eli Lilly's tirzepatide,...

Teva Pharmaceuticals recently reached a significant settlement agreement, agreeing to pay a total of $450 million to address allegations of engaging in kickbacks and price-fixing. This settlement marks the largest of its kind and...